Tempest Therapeutics, Inc. (TPST) Tops Q1 EPS by 4c

Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q1 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• United Community Banks sells equipment finance unit for $1.9 billion